Cancer drug set for NHS fast-track
Friday 24 December 2010
A new drug to treat advanced kidney cancer has been fast-tracked for use on the NHS, a health watchdog said yesterday.
The National Institute for Health and Clinical Excellence (Nice) is recommending Votrient (pazopanib). Pharmaceutical giant GlaxoSmithKline has agreed to a 12.5 per discount to the NHS, following the outcome of a clinical trial, comparing the drug with Sutent (sunitinib), which is already approved.
Dr Carole Longson, from Nice, said: "Pazopanib will offer patients an additional option and, for some, a more favourable side-effect profile."
Each year more than 8,000 new cases of kidney cancer are diagnosed in the UK, and almost half will lead to death.
Life & Style blogs
How Stephen Hawking is still alive, defying ALS and the worst expectations
The black and blue dress: Makers considering a white and gold version
The remarkable archaeological underwater discovery that could open up a new chapter in the study of European and British prehistory
Mother's Day 2015: When is it – and how did it first come about?
Children warned to not listen to music for more than one hour a day
- 1 Forget 'The Dress': Here are five of the biggest news stories you might have missed
- 2 The black and blue dress: Makers considering a white and gold version
- 3 PornHub turns masturbation into energy in bid to save the planet
- 4 The remarkable archaeological underwater discovery that could open up a new chapter in the study of European and British prehistory
- 5 Saudi Muslim cleric claims the Earth is 'stationary' and the sun rotates around it
£9 per hour: Recruitment Genius: This role is based within a small family run ...
£28000 - £32000 per annum: Recruitment Genius: This Design and marketing agenc...
£46000 per annum: Recruitment Genius: This property investment firm are lookin...
£18000 - £35000 per annum: Recruitment Genius: This company specialises provid...